Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

difficile or C. diff. In animal models, this first mRNA-LNP C ... difficile vaccines available, and the main treatment for the infection is a lengthy course of antibiotics. However, because ...

Ferring Pharma has reported what it says is the first positive phase ... the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes ...

The pathogen C. diff—the most common cause of health care-associated infectious diarrhea—can use a compound that kills the ...

Most people recover from C. diff infection during the first course of treatment, while others may require additional medical ...

difficile treatment. Oral FZ002 is a live yeast genetically modified to express a tetraspecific anti-toxin for C. difficile in the gastrointestinal (GI) tract. FZ002 is a first-in-class multi ...

New insights into a "friendly virus" that could pave the way for cutting-edge treatments for the potentially fatal superbug C. diff have ... to the front-line drug used for treatment in the ...